EN
HI
Summary
As of 19 Sep, 2026, Syncom Formulations (India) stock price is ₹20.04. During the trading session, the stock has moved between an intraday low of ₹18.80 and an intraday high of ₹20.25. Over the last 52 weeks, Syncom Formulations (India) has traded between ₹10.21 and ₹22.59.
The stock has recorded a trading volume of 1,02,60,532 shares,. Its Average Traded Price (ATP) is ₹19.84, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 8 @ ₹20.04.
Syncom Formulations (India) has an upper circuit limit of ₹24.04 and a lower circuit limit of ₹16.04. The total value traded stands at ₹20.36 CR, and the delivery percentage for the day is 31.7%.
The stock is currently traded with a market lot size of 1. Syncom Formulations (India) also offers a dividend yield of 0%.
Syncom Formulations (India) Share Price Chart
Syncom Formulations (India) Share Key Metrics
Volume
1.03 CR
Market Cap
1883.76 CR
LTQ@LTP
8@20.04
ATP
19.84
Var Margin
50 %
Circuit Range
16.04-24.04
Delivery %
31.7 %
Value
20.36 CR
ASM/GSM
No
Market Lot
1
Syncom Formulations (India) Fundamentals
P/E Ratio
20.66
P/B Ratio
4.02
Div. Yield
0
Sector P/E
40.93
Sector P/B
3.56
Sec. Div. Yield
0.51
Syncom Formulations (India) Resistance and Support
Pivot 18.66
Resistance
First Resistance
19.16
Second Resistance
19.55
Third Resistance
20.05
Support
First Support
18.27
Second Support
17.77
Third Support
17.38
Syncom Formulations (India) Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 18 2026 | 18.8 | 20.04 | 6.71% | 20.25 | 18.8 |
| Thu Sep 17 2026 | 18.39 | 18.78 | 2.07% | 19.04 | 18.15 |
| Wed Sep 16 2026 | 18.55 | 18.4 | -0.70% | 18.87 | 16.61 |
Syncom Formulations (India) Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-05-22 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-10 | Quarterly Results & Others |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
Syncom Formulations (India) News
Syncom Formulations India Ltd-$ - 524470 - Corporate Announcement/Information Under Regulation 42 Of SEBI (LODR) Regulations, 2015 Regarding Record Date.
Syncom Formulations established September 23, 2026, as the record date for the final dividend. Shareholders will be entitled to a ₹0.10 dividend per equity share for FY 2025-26, upon AGM approval.
Sep 18 2026 11:49:23
Syncom Formulations India Ltd-$ - 524470 - Submission Of The Notice Of 38Th Annual General Meeting To Be Held On Wednesday 30Th September, 2026.
Syncom Formulations will convene its 38th Annual General Meeting on September 30, 2026. The agenda includes the approval of financial statements for FY26, the appointment of Mr. Rahul Vijay Bankda as Managing Director and Mrs. Rinki Ankit Bankda as Whole-Time Director, and the declaration of a Rs. 0.10 per share dividend for FY26 with a record date of September 23, 2026.
Sep 07 2026 18:46:27
Syncom Formulations (India) Management
| Name | Position |
|---|---|
| Vaishali Agrawal | Company Secretary & Compliance Officer |
| Vijay Shankarlal Bankda | Managing Director |
Syncom Formulations (India) Similar Stocks
Windlas Biotech Ltd.
1109.45
-8.15 (0.73%)
Venus Remedies Ltd.
0.00
0.00 (0.00%)
Fredun Pharmaceuticals Ltd.
1303.50
25.30 (1.98%)
Hester Biosciences Ltd.
2195.60
-50.20 (2.24%)
Krsnaa Diagnostics Ltd.
541.15
0.10 (0.02%)
Suraksha Diagnostic Ltd.
335.10
6.15 (1.87%)
NGL Fine-Chem Ltd.
2768.20
52.90 (1.95%)
Q-Line Biotech Ltd.
696.95
-25.15 (3.48%)
Shalby Ltd.
137.66
-0.84 (0.61%)
Syncom Formulations (India) FAQs
The Buying Price of Syncom Formulations (India) share is 20.04 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Syncom Formulations (India) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Syncom Formulations (India), choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Syncom Formulations (India) shares is 20.66. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Syncom Formulations (India) shares is 4.02. Useful to assess the stock's value relative to its book value.
To assess Syncom Formulations (India)’s valuation compare Sector P/E, P/B which are 40.93 & 3.56 with sector averages, along with growth rates and financial metrics.
The Market Cap of Syncom Formulations (India) is 1883.76 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Syncom Formulations (India) share price is 22.59 & 10.21. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Syncom Formulations (India) belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in SYNCOMF
